Positron Corporation (POSC)

[metical1]

I grabbed a few of these thursday, this thing is cruising...Nice news to boot:

Positron Corporation Receives Positive Feedback at Society of Nuclear Medicine Meeting

HOUSTON, Jun 19, 2008 (BUSINESS WIRE) -- Positron Corporation (OTC: POSC) (the "Company") recently displayed their molecular imaging and automated radioisotope dose drawing systems at the Society of Nuclear Medicine Meeting in New Orleans, Louisiana. Approximately 3,900 attendees and over 180 exhibiting companies attended the meeting. The Society of Nuclear Medicine meeting is the world's largest event focused exclusively on the latest developments in molecular imaging technology and nuclear medicine based products and services.

"We received a great deal of positive feedback on our recent acquisition of Dose Shield Corporation and the integration of our product portfolio under one brand allowing for the sale of a turn-key solution encompassing imaging system, dose dispensing system, radiopharmaceutical and disease management software," stated Joe Oliverio, President of Positron. "Of particular note," continued Mr. Oliverio, "potential customers were pleasantly surprised to hear of our upcoming market release of an economically priced PET system that is design optimized for cardiology applications We are not aware of any other company selling a PET only into the USA market. We look forward to meeting the demand for a more economical product in cardiac PET, and our goal is to be delivering devices immediately after receiving our FDA 510k approval."

About Positron Corporation

Positron Corporation is a growing healthcare company offering cardiac molecular imaging solutions that will transform the delivery of healthcare through radiopharmaceutical development, advancing imaging technology and by introducing unique disease management applications into the market. Positron Corporation designs, manufactures and sells SPECT, PET and automated dose delivery devices in to the Nuclear Medicine market. Additional information may be found at http://www.positron.com/.

Forward-Looking Statements

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by Positron Corporation are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied including the success of the Company's research and development efforts, the availability of adequate financing and other uncertainties described in the "Management's Discussion and Analysis" section of the Company's Form 10-KSB and other reports and filings with the Securities and Exchange Commission.

For any additional information contact Positron's President, Joe Oliverio at [phone].

SOURCE: Positron Corporation

CONTACT: Positron
Joe Oliverio at [phone]